SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Phone858-847-0200
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees5
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable
SpectraScience (OTCMKTS:SCIE) Frequently Asked Questions
What is SpectraScience's stock symbol?
SpectraScience trades on the OTCMKTS under the ticker symbol "SCIE."
When is SpectraScience's next earnings date?
Has SpectraScience been receiving favorable news coverage?
News coverage about SCIE stock has been trending negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. SpectraScience earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the next few days. View News Stories for SpectraScience.
Who are some of SpectraScience's key competitors?
Some companies that are related to SpectraScience include Medtronic (MDT), SONOVA HLDG AG/ADR (SONVY), Varian Medical Systems (VAR), Masimo (MASI), GETINGE AB/ADR (GNGBY), LivaNova (LIVN), CONMED (CNMD), Natus Medical (NTUS), Natus Medical (BABY), InMode (INMD), AxoGen (AXGN), Cutera (CUTR), TransMedics Group (TMDX), BioLife Solutions (BLFS) and Zynex (ZYXI).
What other stocks do shareholders of SpectraScience own?
Who are SpectraScience's key executives?
SpectraScience's management team includes the folowing people:
- Mr. Michael P. Oliver, CEO, Pres, COO & Director (Age 71)
- Mr. Lowell W. Giffhorn, CFO & Sec. (Age 72)
How do I buy shares of SpectraScience?
Shares of SCIE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is SpectraScience's stock price today?
One share of SCIE stock can currently be purchased for approximately $0.00.
How big of a company is SpectraScience?
What is SpectraScience's official website?
How can I contact SpectraScience?
SpectraScience's mailing address is 11568 SORRENTO VALLEY ROAD SUITE 11, SAN DIEGO CA, 92121. The company can be reached via phone at 858-847-0200.
MarketBeat Community Rating for SpectraScience (OTCMKTS SCIE)
MarketBeat's community ratings are surveys of what our community members think about SpectraScience and other stocks. Vote "Outperform" if you believe SCIE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCIE will underperform the S&P 500 over the long term. You may vote once every thirty days.
